The use of unique device identifiers is intended to improve patient safety by allowing FDA regulators to track devices on a unit level and recall defective products more easily.
The UDIs will be phased in over the next seven years, beginning with high-risk devices like pacemakers and artificial joints.
More Articles on FDA Regulation:
Michigan Bill Calls for FDA Regulation of Medical Apps
The Case for Integrated Clinical Decision Support Software in EMRs
FDA: How to Use Radio-Frequency Wireless Healthcare Devices
